On Friday February 24th 2023, Josefine Hammer Jakobsen successfully defended her PhD thesis with the title “Diversity of the Prodrug Design – In Treatment of Infection and Synthetic Transmembrane Signalling“. We are all very proud of you Josefine, and we can’t wait to see what the future holds!
